Systemic Infusion of Expanded CD133(+) Cells and Expanded CD133(+) Cell-Derived EVs for the Treatment of Ischemic Cardiomyopathy in a Rat Model of AMI

Myocardial infarction is a leading cause of death among all cardiovascular diseases. Cell therapies using a cell population enriched with endothelial progenitor cells (EPCs), expanded CD133(+) cells, have promise as a therapeutic option for the treatment of ischemic areas after infarction. Recently,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cells Int
Main Authors: Angulski, Addeli B. B., Capriglione, Luiz Guilherme A., Barchiki, Fabiane, Brofman, Paulo, Stimamiglio, Marco A., Senegaglia, Alexandra C., Correa, Alejandro
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6914904/
https://ncbi.nlm.nih.gov/pubmed/31885610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/4802578
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados